Dr. Neha Vyas

Dr. Janet L. Crane is an Associate Professor of Pediatrics at the Johns Hopkins University School of Medicine. Dr. Crane is the Director of the Pediatric Bone Health Program, which focuses on the care of children with rare metabolic bone diseases and osteoporosis/skeletal fragility syndromes. Dr. Crane received her bachelor’s degree in nutritional science from the University of Missouri. She completed her medical degree at the University of Maryland-Baltimore, residency in pediatrics at Children's Mercy Hospital and Clinics in Kansas City, Missouri and fellowship in pediatric endocrinology at Johns Hopkins University in 2013. Dr. Crane is a faculty member of the Center for Musculoskeletal Research. Her research is focused on bone modeling and remodeling factors that result in proper bone growth and strength. The goal of her studies is to identify diagnostic markers and therapeutic targets to enhance bone strength in children who have recurrent fractures. Dr. Crane also participates in industry sponosored clinical studies to investigate the safety and efficacy of medications for metabolic bone disease and skeletal fragility. Dr. Crane is rated as an Experienced provider by MediFind in the treatment of Hypoaldosteronism. Her top areas of expertise are Osteogenesis Imperfecta, Juvenile Primary Osteoporosis, Short Stature (Growth Disorders), and Noonan Syndrome.

Dr. Malinda Wu is a pediatric endocrinologist seeing patients at the Johns Hopkins Children’s Center in Baltimore, Maryland. She specializes in a wide range of pediatric endocrine conditions including metabolic bone disease, pediatric osteoporosis and cystic fibrosis endocrinopathies. Dr. Wu received her M.D. from Jefferson Medical College, Thomas Jefferson University. She completed pediatrics residency at Penn State Hershey Medical Center and her pediatric endocrine fellowship at Emory University School of Medicine. She received her Master of Science in Clinical Research from Emory University (2021). Dr. Wu has been a faculty member at Johns Hopkins since 2021. Dr. Wu’s research interests are in metabolic bone disease and the health of women with cystic fibrosis. Dr. Wu’s current research is focused on women with cystic fibrosis and how estrogen supplementation may impact their health. She has received grant funding from the Cystic Fibrosis Foundation. Dr. Wu is rated as an Advanced provider by MediFind in the treatment of Hypoaldosteronism. Her top areas of expertise are Osteogenesis Imperfecta, Hypogonadism, Malnutrition, Exocrine Pancreatic Insufficiency, and Hormone Replacement Therapy (HRT).